<SEC-DOCUMENT>0001193125-24-286248.txt : 20241230
<SEC-HEADER>0001193125-24-286248.hdr.sgml : 20241230
<ACCEPTANCE-DATETIME>20241230091159
ACCESSION NUMBER:		0001193125-24-286248
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241223
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241230
DATE AS OF CHANGE:		20241230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DELCATH SYSTEMS, INC.
		CENTRAL INDEX KEY:			0000872912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				061245881
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16133
		FILM NUMBER:		241587055

	BUSINESS ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804
		BUSINESS PHONE:		(518) 743-8892

	MAIL ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DELCATH SYSTEMS INC
		DATE OF NAME CHANGE:	19990607
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d924758d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dcth="http://www.delcath.com/20241223" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2024-12-23_to_2024-12-23">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-304">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-12-23_to_2024-12-23">0000872912</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="dcth-20241223.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-12-23_to_2024-12-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-23</xbrli:startDate> <xbrli:endDate>2024-12-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-315">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt:datemonthdayyearen" id="ixv-316">December 23, 2024</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-317">Delcath Systems, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:stateprovnameen" id="ixv-318">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-319">001-16133</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-320">06-1245881</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-321">566 Queensbury Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-322">Queensbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:stateprovnameen" id="ixv-323">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-324">12804</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-325">(212)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-326">489-2100</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:boolballotbox" id="ixv-327">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:boolballotbox" id="ixv-328">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:boolballotbox" id="ixv-329">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:boolballotbox" id="ixv-330">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-331">Common Stock, $0.01 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-332">DCTH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-12-23_to_2024-12-23" format="ixt-sec:boolballotbox" id="ixv-333">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;30, 2024, Delcath Systems, Inc. (the &#8220;Company&#8221;) issued a press release announcing aggregate gross proceeds as a result of the exercise of the Existing Warrants (as defined below), a copy of which is furnished as Exhibit 99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The information furnished under Item 7.01 of this Current Report <span style="white-space:nowrap">on&#160;Form&#160;8-K,&#160;including</span> Exhibit 99.1, is being furnished and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </span></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Warrant Amendment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;23, 2024, the Company entered into warrant amendments (each, a &#8220;Warrant Amendment&#8221; and collectively, the &#8220;Warrant Amendments&#8221;) with existing institutional stockholders, pursuant to which the stockholders, as the holders of warrants to purchase up to an aggregate of 854,000 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;) upon the conversion of series E warrants and series <span style="white-space:nowrap">E-1</span> warrants (together, the &#8220;Existing Warrants&#8221;), agreed to amend the Existing Warrants to provide for the option to subscribe for and purchase from the Company Warrant Shares (as defined in the Existing Warrants) and/or, in lieu of Common Stock otherwise represented by Warrant Shares, <span style="white-space:nowrap">pre-funded</span> warrants to purchase shares of Common Stock (the <span style="white-space:nowrap">&#8220;Pre-Funded</span> Warrants&#8221;), if the exercise of the Existing Warrants would cause the stockholders (together with their respective affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with such stockholder for the purposes of Section&#160;13(d) of the Securities Exchange Act of 1934, as amended) to beneficially own in excess of 9.99% of the total number of then issued and outstanding shares of Common Stock, as such percentage ownership is determined in accordance with the Existing Warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <span style="white-space:nowrap">Pre-Funded</span> Warrants have an exercise price of $0.01 per underlying share of Common Stock, are immediately exercisable and will not expire until exercised in full. The number of shares of Common Stock issuable upon exercise of the <span style="white-space:nowrap">Pre-Funded</span> Warrants is subject to adjustment upon certain corporate events, including certain stock dividends and splits, combinations, reclassifications, and certain other events. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stockholders will not be entitled to exercise any portion of the <span style="white-space:nowrap">Pre-Funded</span> Warrants that, upon giving effect to such exercise, would cause the aggregate number of shares of Common Stock beneficially owned by such stockholder (together with its affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with such stockholder for the purposes of Section&#160;13(d) of the Securities Exchange Act of 1934, as amended) to exceed 9.99% of the total number of then issued and outstanding shares of Common Stock, as such percentage ownership is determined in accordance with the terms of the <span style="white-space:nowrap">Pre-Funded</span> Warrant. This threshold is subject to such stockholder&#8217;s rights under the <span style="white-space:nowrap">Pre-Funded</span> Warrant to increase or decrease such percentage to any other percentage not in excess of 19.99% upon at least 61 days&#8217; prior notice from it to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the <span style="white-space:nowrap">Pre-Funded</span> Warrant is filed herewith as Exhibit 4.1 and is incorporated herein by reference. The foregoing description of the <span style="white-space:nowrap">Pre-Funded</span> Warrant does not purport to be complete and is qualified in its entirety by reference to such exhibit. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Warrant Exercises </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;24, 2024, the Existing Warrants expired per their term and as of the date thereof an aggregate of 1,746,424 Existing Warrants were exercised for an aggregate of 1,045,157 shares of Common Stock and 603,954 <span style="white-space:nowrap">Pre-Funded</span> Warrants. As a result of such exercises, the Company received gross proceeds of approximately $16.3&#160;million. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d924758dex41.htm">Form of Amendment <span style="white-space:nowrap">Pre-Funded</span> Warrant. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d924758dex991.htm">Press Release, dated December&#160;30, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL (eXtensible Business Reporting Language) document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:43%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:9%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:42%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">Delcath Systems, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December&#160;30, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gerard Michel</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name: Gerard Michel</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title: Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d924758dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PRE-FUNDED</FONT> COMMON STOCK PURCHASE WARRANT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELCATH SYSTEMS, INC. </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warrant Shares: [&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Issue Date: December&nbsp;23, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Initial Exercise Date: December&nbsp;23, 2024</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">THIS <FONT STYLE="white-space:nowrap">PRE-FUNDED</FONT> COMMON STOCK PURCHASE WARRANT (the
&#147;<U>Warrant</U>&#148;) certifies that, for value received, [&#149;], or its assigns (the &#147;<U>Holder</U>&#148;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date hereof (the &#147;<U>Initial Exercise Date</U>&#148;) and until this Warrant is exercised in full, to subscribe for and purchase from Delcath Systems, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), up to 854,000
shares of common stock, par value $0.01 per share (&#147;<U>Common Stock</U>&#148;) (as subject to adjustment hereunder, the &#147;<U>Warrant Shares</U>&#148;). The purchase price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section&nbsp;2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;1</U>. <U>[Reserved]</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;2</U>. <U>Exercise</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Exercise of Warrant</U>. The Holder may exercise this Warrant, in whole or in part, at any time or times on or after the
Initial Exercise Date by delivery to the Company of a duly executed PDF copy submitted by <FONT STYLE="white-space:nowrap">e-mail</FONT> attachment of the Notice of Exercise in the form annexed hereto (the &#147;<U>Notice of Exercise</U>&#148;).
Within the number of days on which the Company&#146;s principal Trading Market (as defined below) is open (&#147;<U>Trading Days</U>&#148;) comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i) herein) following the date of
exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#146;s check drawn on a United States bank, in either case in immediately
available funds, unless the cashless exercise procedure specified in Section&nbsp;2(c) below is specified in the applicable Notice of Exercise.<B> </B>No <FONT STYLE="white-space:nowrap">ink-original</FONT> Notice of Exercise shall be required, nor
shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Company shall have no obligation to inquire with respect to or otherwise confirm the authenticity of the signature(s) contained on
any Notice of Exercise nor the authority of the person so executing such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has
purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days of the date on which the
final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise within one (1)&nbsp;Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>Exercise Price</U>. The aggregate exercise price of this Warrant,
except for a nominal exercise price of $0.01 per Warrant Share, was <FONT STYLE="white-space:nowrap">pre-funded</FONT> to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal
exercise price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.01, subject to
adjustment hereunder (the &#147;<U>Exercise Price</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Cashless Exercise</U>. This Warrant may also be
exercised, in whole or in part, at such time by means of a &#147;cashless exercise&#148; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing
<FONT STYLE="white-space:nowrap">[(A-B)</FONT> (X)] by (A), where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(A)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">as applicable: (i)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a) hereof on a day
that is not a Trading Day or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a) hereof on a Trading Day prior to the opening of &#147;regular trading hours&#148; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the
federal securities laws) on such Trading Day, (ii)&nbsp;at the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z)&nbsp;the Bid Price of the Common Stock on any
of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market or the New
York Stock Exchange, OTCQB or OTCQX, or the &#147;Pink Sheets&#148; published by OTC Markets Group, Inc. (or any successors to any of the foregoing) (the &#147;<U>Trading Market</U>&#148;) as reported by Bloomberg L.P. as of the time of the
Holder&#146;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#147;regular trading hours&#148; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours
after the close of &#147;regular trading hours&#148; on a Trading Day) pursuant to Section&nbsp;2(a) hereof or (iii)&nbsp;the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such
Notice of Exercise is both executed and delivered pursuant to Section&nbsp;2(a) hereof after the close of &#147;regular trading hours&#148; on such Trading Day;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(B)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(X)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Warrant Shares are
issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of
the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section&nbsp;2(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bid Price</U>&#148; means, for any date, the price determined by the first of the following clauses that applies:
(a)&nbsp;if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as
reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
price per share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants
then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>VWAP</U>&#148; means, for any date, the price determined by the first of the following clauses that applies:
(a)&nbsp;if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or
quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Mechanics of Exercise</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be
transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#146;s or its designee&#146;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#147;<U>DWAC</U>&#148;) if
the Company&#146;s transfer agent is then a participant in such system and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B)&nbsp;the
Warrant Shares are eligible for resale by the Holder without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and
otherwise by physical delivery of a certificate, registered in the Company&#146;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is the then the number of Trading days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#147;<U>Warrant Share
Delivery Date</U>&#148;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of
the date of delivery of the Warrant Shares, provided that the Company shall have received payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the number of Trading Days comprising the Standard
Settlement Period at the time of delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Exercise by the Warrant Share Delivery Date, the Company shall pay, beginning one Trading Day after the Warrant Share Delivery Date, to the Holder, in cash, as liquidated damages and not as a
penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the
FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#147;Standard Settlement Period&#148; means the standard settlement period, expressed in a number of Trading Days, on the Company&#146;s primary Trading
Market with respect to the Common Stock as in effect on the date of the delivery of the Notice of Exercise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares remaining available under this Warrant, which new Warrant shall in all other respects be identical with this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">iii. <U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
pursuant to Section&nbsp;2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company at any time prior to the delivery of such Warrant Shares (in which case any
liquidated damages payable under Section&nbsp;2(d)(i) shall no longer be payable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">iv. <U>Compensation for <FONT
STYLE="white-space:nowrap">Buy-In</FONT> on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant
Shares in accordance with the provisions of Section&nbsp;2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or
otherwise) or the Holder&#146;s brokerage firm otherwise purchases for the Holder, Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#147;<U><FONT
STYLE="white-space:nowrap">Buy-In</FONT></U>&#148;), then the Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&#146;s total purchase price (including reasonable and customary brokerage commissions, if
any) for the Common Stock so purchased exceeds (y)&nbsp;the amount obtained by multiplying (1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)&nbsp;the price
at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
purchases shares of Common Stock having a total purchase price of $11,000 to cover a <FONT STYLE="white-space:nowrap">Buy-In</FONT> with respect to an attempted exercise of Common Stock with an
aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice
indicating the amounts payable to the Holder in respect of the <FONT STYLE="white-space:nowrap">Buy-In</FONT> and evidence of the amount of such loss. Nothing herein shall limit a Holder&#146;s right to pursue any other remedies available to it
hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#146;s failure to timely deliver Common Stock upon exercise of the Warrant as required pursuant to
the terms hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">v. <U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses
shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a
name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum
sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for <FONT STYLE="white-space:nowrap">same-day</FONT> processing of any Notice of Exercise and all fees to the Depository Trust
Company (or another established clearing corporation performing similar functions) required for <FONT STYLE="white-space:nowrap">same-day</FONT> electronic delivery of the Warrant Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">vii. <U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the
timely exercise of this Warrant, pursuant to the terms hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Holder&#146;s Exercise Limitations</U>. The Company
shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such issuance after exercise as set
forth on the applicable Notice of Exercise, the Holder (together with the Holder&#146;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#146;s Affiliates (such Persons, &#147;<U>Attribution
Parties</U>&#148;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and
Attribution Parties shall include the number of such shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i)&nbsp;exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
(including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder
or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section&nbsp;2(e), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d) of the Exchange Act and the rules
and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section&nbsp;13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith and the calculations required under this Section&nbsp;2(e). To the extent that the limitation contained in this Section&nbsp;2(e) applies, the determination of whether this Warrant is
exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice
of Exercise shall be deemed to be the Holder&#146;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section&nbsp;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A)&nbsp;the Company&#146;s most recent periodic or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement or filing by the
Company or (C)&nbsp;a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within one Trading Day confirm orally and
in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#147;<U>Beneficial Ownership Limitation</U>&#148; shall be 9.99% of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section&nbsp;2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day
after such notice is delivered to the Company. The provisions of this Section&nbsp;2(e) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e) to correct this Section&nbsp;2(e) (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;3</U>. <U>Certain
Adjustments</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Share Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding:
(i)&nbsp;pays a share dividend or otherwise makes a distribution or distributions in respect of the Company&#146;s Common Stock (which, for avoidance of doubt, shall not include any Common Stock issued by the Company upon exercise of this Warrant),
(ii)&nbsp;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&nbsp;combines (including by way of reverse share </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&nbsp;issues by reclassification of Common Stock any shares of capital stock of the Company, then in each case
the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any
adjustment made pursuant to this Section&nbsp;3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or <FONT STYLE="white-space:nowrap">re-classification.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b)
<U>[RESERVED]</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;3(a)
above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of Common Stock (the &#147;<U>Purchase Rights</U>&#148;), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Stock acquirable upon complete exercise of this
Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if
no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&#146;s right to
participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company
shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of shares or other
securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#147;<U>Distribution</U>&#148;), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of
this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&#146;s right to participate in any such Distribution would
result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such
Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation);
provided, that the Holder&#146;s right to receive such Distribution shall terminate on, and shall not be held in abeyance for any period subsequent to the Termination Date. </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Fundamental Transaction</U>. If, at any time while this Warrant is
outstanding, (i)&nbsp;the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person (other than for the purpose
of changing the Company&#146;s name and/or the jurisdiction of incorporation of the Company or a holding company for the Company), (ii)&nbsp;the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or
other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of Common Stock, (iv)&nbsp;the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, <FONT STYLE="white-space:nowrap">spin-off,</FONT> merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of
Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such share purchase agreement or other business combination)
(each a &#147;<U>Fundamental Transaction</U>&#148;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the &#147;<U>Alternate Consideration</U>&#148;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a
Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall require any successor entity in a
Fundamental Transaction in which the Company is not the survivor (the &#147;<U>Successor Entity</U>&#148;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section&nbsp;3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the
shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#147;Company&#148; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">f) <U>Calculations</U>. All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of
a share, as the case may be. For purposes of this Section&nbsp;3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if
any) issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">g) <U>Notice to Holder</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. <U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this
Section&nbsp;3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement
of the facts requiring such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">ii. <U>Notice to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall
declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the Company shall authorize the granting to
all holders of Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall
cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
hereinafter specified, a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the
Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
Common Stock of record shall be entitled to exchange their Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
in this Warrant constitutes, or contains, material, <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as
may otherwise be expressly set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;4</U>. <U>Transfer of Warrant</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in
Section&nbsp;4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon
such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of
assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to
physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid
office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section&nbsp;4(a), as to any transfer
which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers
or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c) <U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that
purpose (the &#147;<U>Warrant Register</U>&#148;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or
any distribution to the Holder, and for all other purposes, absent actual notice to the contrary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Transfer Restrictions</U>. If, at the time of the surrender of this
Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i)&nbsp;registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky
laws or (ii)&nbsp;eligible for resale without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions or current public information requirements pursuant to Rule&nbsp;144, the Company may
require, as a condition of allowing such transfer, that such transferee agrees in writing to be bound, with respect to the Holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this
Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;5</U>. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a) <U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any
voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except as expressly set forth in Section&nbsp;3. Without limiting any rights of a Holder to receive Warrant
Shares on a &#147;cashless exercise&#148; pursuant to Section&nbsp;2(c) or to receive cash payments pursuant to Section&nbsp;2(d)(i) and Section&nbsp;2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this
Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b) <U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share
certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on
the next succeeding Trading Day. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d) <U>Authorized Shares</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
share capital a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued
upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except and to the extent as waived or consented to by the Holder, the
Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii)&nbsp;take such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the
exercise of this Warrant and (iii)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction
thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">e) <U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of
this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">f) [<U>RESERVED]</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">g) <U>Nonwaiver; Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of
Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#146;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to
comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&#146; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">h) <U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the
Company shall be in writing and shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth below at or prior to 5:30
p.m. (New York City time) on a Trading Day or (b)&nbsp;the next Trading Day after the time of transmission, if such notice is delivered via email attachment at the email address below on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time). Any notice, request or other document required or permitted to be given or delivered to the Company by the Holder shall be delivered via email to <U>dhoffman@delcath.com</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">i) <U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this
Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such
liability is asserted by the Company or by creditors of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">j) <U>Remedies</U>. The Holder, in addition to being entitled to exercise
all rights granted by law, including recovery of damages, will be entitled to seek specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation for any loss incurred by reason of a
breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">k) <U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
time to time of this Warrant and shall be enforceable by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">l) <U>Amendment</U>. This Warrant may be modified or
amended or the provisions hereof waived with the written consent of the Company and the Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">n) <U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">o) <U>Facsimile and Electronic Signatures</U>. Facsimile and other electronically
scanned and transmitted signatures, including by email attachment, shall be deemed originals for all purposes of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">******************** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
thereunto duly authorized as of the date first above indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DELCATH SYSTEMS, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF EXERCISE </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">TO:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">DELCATH SYSTEMS, INC. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2)
Payment shall take the form of (check applicable box): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[&#8195;] in lawful money of the United States; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">[&#8195;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Shares shall be delivered to the following DWAC Account Number: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) <U>Accredited Investor</U>. The undersigned is an &#147;accredited investor&#148; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[SIGNATURE OF HOLDER] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Investing Entity: _____________________________________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Signature of Authorized Signatory of Investing Entity</I>: _______________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name of Authorized Signatory: _________________________________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of Authorized Signatory: __________________________________________________________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: ______________________________________________________________________________________________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>&#8195;(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Please Print)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Please Print)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Phone Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: ______________________ __, ______</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Holder&#146;s Signature: _______________________</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Holder&#146;s Address: ________________________</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d924758dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Delcath Systems Announces Additional $16.3 Million in Funding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>From Series E and E1 Warrant Exercises </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">QUEENSBURY, NY &#150; December&nbsp;30, 2024, Delcath Systems, Inc. (Nasdaq: DCTH) (&#147;Delcath&#148; or the &#147;Company&#148;), an interventional
oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the exercise of 1.7&nbsp;million Series E and E1 warrants which resulted in $16.3&nbsp;million of funding. Approximately 6.6% of the warrants
exercised were subject to cashless exercise provisions. The warrants, issued in July and August 2019 as a component of a private placement, had an exercise price of $10.00 per share and expired on December&nbsp;24, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;With the exercise of these warrants, current cash on hand and cash expected from operations as a result of our revenue growth, we believe that we are in
a strong position to execute on our ongoing commercialization efforts and our robust clinical development plan.,&#148; said Gerard Michel, Delcath&#146;s Chief Executive Officer. Mr.&nbsp;Michel continued, &#147;As we continue to drive the
commercial success of HEPZATO to treat uveal melanoma patients we can confidently invest in new clinical trials.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Delcath Systems, Inc.,
HEPZATO KIT and CHEMOSAT </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers.
The company&#146;s proprietary products, HEPZATO KIT<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> (HEPZATO (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP), are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, HEPZATO KIT is considered a combination drug and device product and is regulated and approved for sale as a drug by the FDA. HEPZATO KIT
is comprised of the chemotherapeutic drug melphalan and Delcath&#146;s proprietary Hepatic Delivery System (HDS). The HDS is used to isolate the hepatic venous blood from the systemic circulation while simultaneously filtrating hepatic venous blood
during melphalan infusion and washout. The use of the HDS results in loco-regional delivery of a relatively high melphalan dose, which can potentially induce a clinically meaningful tumor response with minimal hepatotoxicity and reduce systemic
exposure. HEPZATO KIT is approved in the United States as a liver-directed treatment for adult patients with metastatic uveal melanoma (mUM) with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or
extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation. Please see the full <U>Prescribing Information</U>, including BOXED WARNING for the HEPZATO KIT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Europe, the device-only configuration of the HDS is regulated as a Class&nbsp;III medical device and is approved for sale under the trade name CHEMOSAT
Hepatic Delivery System for Melphalan, or CHEMOSAT, where it has been used in the conduct of percutaneous hepatic perfusion procedures at major medical centers to treat a wide range of cancers of the liver. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor / Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Private
Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This press release contains forward-looking statements, which are subject to certain risks and uncertainties, that
can cause actual results to differ materially from those described. The words &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148;
&#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions are intended to identify forward-looking statements, although not
all forward-looking statements contain these identifying words. Factors that may cause such differences include, but are not limited to, uncertainties relating to: the Company&#146;s commercialization plans and its ability to successfully
commercialize the HEPZATO KIT; the Company&#146;s successful management of the HEPZATO KIT supply chain, </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
including securing adequate supply of critical components necessary to manufacture and assemble the HEPZATO KIT; successful FDA inspections of the facilities of the Company and those of its
third-party suppliers/manufacturers; the Company&#146;s successful implementation and management of the HEPZATO KIT Risk Evaluation and Mitigation Strategy; the potential benefits of the HEPZATO KIT as a treatment for patients with primary and
metastatic disease in the liver; the Company&#146;s ability to obtain reimbursement for the HEPZATO KIT; and the Company&#146;s ability to successfully enter into any necessary purchase and sale agreements with users of the HEPZATO KIT. For
additional information about these factors, and others that may impact the Company, please see the Company&#146;s filings with the Securities and Exchange Commission, including those on Forms <FONT STYLE="white-space:nowrap">10-K,</FONT> <FONT
STYLE="white-space:nowrap">10-Q,</FONT> and <FONT STYLE="white-space:nowrap">8-K.</FONT> However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. Accordingly, you
should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the
date they are made. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ICR Healthcare </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@delcath.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dcth-20241223.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/30/2024 12:18:30 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:dcth="http://www.delcath.com/20241223"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.delcath.com/20241223"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20241223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dcth-20241223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>dcth-20241223_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/30/2024 12:18:30 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>dcth-20241223_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/30/2024 12:18:30 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dcth-20241223.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45613762257680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000872912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 23,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Delcath Systems, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1245881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">566 Queensbury Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Queensbury<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">489-2100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DCTH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX!!QK@(\7REE7PON(%O]#S'Z#U!+ P04    " !]29Y9GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( 'U)GED<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !]29Y9!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M 'U)GEF=:*'L[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( 'U)GEF97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ?4F>62?L
M"X]*!   DQ   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( 'U)GEF?H!OPL0(  .(,   -
M  "  8X,  !X;"]S='EL97,N>&UL4$L! A0#%     @ ?4F>69>*NQS
M$P(   L              ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @
M?4F>61PX9>H_ 0  / (   \              ( !4Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( 'U)GEDD'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( 'U)
MGEEED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d924758d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d924758d8k.htm">d924758d8k.htm</File>
    <File>dcth-20241223.xsd</File>
    <File>dcth-20241223_lab.xml</File>
    <File>dcth-20241223_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d924758d8k.htm": {
   "nsprefix": "dcth",
   "nsuri": "http://www.delcath.com/20241223",
   "dts": {
    "inline": {
     "local": [
      "d924758d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "dcth-20241223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dcth-20241223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dcth-20241223_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-12-23_to_2024-12-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d924758d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-12-23_to_2024-12-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d924758d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.delcath.com//20241223/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-286248-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-286248-xbrl.zip
M4$L#!!0    ( 'U)GED,H=I@M!,  +)[   .    9#DR-#<U.&0X:RYH=&WM
M76MSXD;6_NY?T44V&[N*FP#;@#UL.9A)7)FQO<:I9/=+JI$:Z(R0E.Z6@??7
MO^=T2T+B8K"Y>";KJ4H,4JLOY_J<TZ?%Y;\F(Y<\,2&Y[WWXP2J6?R#,LWV'
M>X,//UQUVS<W/_RK=70Y5- ,FGJRZ3#^(3=4*FB62I.><(N2V<6!_U2"&Z5*
MN5++10U#65#3@,FD=9_*7M$7@U)\)]/<\STO'"6-Q^-Q47>/#SA*E/")$C0J
M0"LFN!T_-W&Y]R7SV+BJ'[(:C49)WXV;+K1,!JB4R]42WNY1R>+FCJV&F>8.
M<VVJAD7;'^FI6Y5*-9F&Y,LF 1U;I=\_?^K:0S:B!>Y)13T[&2)48N6$&B6X
M&S?DTJ]5K/-G9A^U2!Z8K&IK05L/ULI^__'ATZRY6MY^UK2D!/5DWQ<CJD!:
ML*?30KE2J)RE.BF -&0ZBJ5C73_U0M5*: F#\^>6.D=%O.O,2674^*QD;D9-
M5\L)2G@.)9U1!_XHKES6JA=^N2R9CT>7(Z8HP<<+[*^0/WW(M7U/,4\5'D$R
M<\0VWS[D%)NHDNZN!$^53(>$D,N>[TQ;EPY_(E)-7?8AYW 9N'2*HL]R+7+)
M)TULS43TF3L.\\QG:')KY)YPYT/N9WWK#U"Y/[K,#@57T\[$'E)OP&[I"&;C
MP?]A ,:;R^_KV4[4 ^M#JU!H3OR!,EVP@*/5/Y2?^I9KW5YUKZ_^?5G*S&1A
M9K-!KT;,<^ _]=&E@Y>.IE?()T^%:KF6:_6I*]FZD>=HTO& :=,VC"^H>^,Y
M;/(+FZ:)LJ+!"ZE2AG_U\TK#JBS.KS3'0,'Z3(!I91*^HZ5I2FT28*Q]&C(]
M$IK.#SG)1X&;7!L*O4@P<878E!4GTHEO4V$+'V5T_2"E:+69%>KOT@^%^:HU
MNAF15W-K _+&CS'-K.0K=_!"GS-!- G94GO3OODERZ#YAW'62_L/@(.^DWP%
M4R/4-56L-9M;_.3LWFRNSHJV\9UDV&2<4H8Z"35GU"NE#4,)# C\29D1?*I
M73[PFC:LA8E<]OZ8.VK8K!=/N7>1:NNROKH843'@7@$_-PD-E1]?$7PPC"YA
M=T'<&5KQPI#INP 7@J0+Y0?-U->>KY0_TE=ZOH"IQU>L8$*D[W*'?%?6_W*M
M?WYGG94O+DO!JH&JZP>JO'J@5+<UZ(0L+H#T@34%R?^/-:UZ\KU/1]R=-A_Y
MB$ERR\;DP1]1[T+?&YMY]WS7N5C"GE]O;QX[UZ3[>/78Z:Z>3OE T^EVVK\^
MW#S>=+KDZO::='YO_WQU^U.'M.\^?[[I=F_N;K>:8V47<_R-RB& 4N5[>7)=
M;!=)I7Q::\S-:V[0=9*9%8AU&K54,L]>)9G%,C3+"N>%T=**]?WBZC?4TMEB
M8B.QC&&&'0>0JH]W#Y_)I0RHEQBB(5>L %=L!LYR+&B0:ZV$$->^'2*"2*&K
M5R (ZS1G4%S6/U^6<%ZM=_'9B_CL1.'!)#UT;A_)0^?^[N'Q[0W0?2AD2#U%
ME$\ 4Z, &HI957+W0*S38^?D[6?I]XD:,A*!?@[/Q[B?7-F*P&VK4:VMGN?!
MV(M8"*?SP )?*'(<?V<4L!"3BK G:$F$OLV<D^;J8".V%/<:4'4,SGJQR3 !
M*9H-U72@@Q$\/G3H= HS8E[:I)S![)G-1CU H)5JGF OBP;FW;+LWK)4:KL0
MO=629,+"!S;@$I,4ZC6Q<DI0SE%0=,J(=*<21$KFR8UG%Y=$BUO8C?(N:'+<
MF5"P#T@*U$*1D(!0263 ;(R9',(]PI4D8%% *<6\O7N7\A52O@UACBX5[;F,
MV,QU$3IA9C97SNGO 76<^'LT5+14VW==&DC6C#\\+R(I>4+L9XAAE<O?1Z1K
MEJ-9-LMQ2 CS$OK_3C;.K-:^QY1 ^L83$XK;U(VH:A8ZWRAZNK+9T_$4%UJG
MN[DL15,4\=V #EBA)QC]@JE8[K F??)!"C:FCJ79DQF1I 2&9"2FJ66%S"T
MV ZP-XV+YQ7T&51L+!08$5^ 8]2FJ*O 6[7]T%-BVO:=K3P?IF\QJZ%8(/PG
M'#;K^NK:HM$QN,25D%HYFW _$?'YYF] SH_<97 /_/D6QKZ!Z2:K8)U9U>K?
MB#:/='(3Y<QL38QM"54I Z'.X'+MM%ZWGJ/4'M2WOAOM?:VOWDE<?:P5GOB"
M^ #U!?D3D+YTN(Y(7@0DK#U,#K #3QNG$^,/WT+NWY9);7\TXE)^#3Q!\T:,
MVO[/LN/FH4LZH\#UITR\.4.R!I7<^L497[31@_\AYOM6(:0.2;;!D*?EG:#
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M%()JDO(&:]"P7HN,R 'EJRQNQ<(0U%X:N(RJA@.365)E@U6WC@@^(9E.\1S
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M!HOL6M=#I3@3;T?L)U%W?0'<Z8HH"5<KR2N&5*8:E0 [H!MVV%\LMXYRA3/
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M6>5P+JY2L!<3K:PIZ</;=$&1=2F7+^":B#)9]_IFPL)<]=7%NQH%\%?'8J#
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MF?&@-^'TT B> Q]+*7.8.%8W5&!910*=65ET4G8_4GE/QB#"!2$8KIE<0((
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M\FV;OH!M4FRR$__ZPG;)A ,&[3#:B_O[;P]_@R]?G;]YO?O_ 5!+ P04
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M]EH81$G1M"*6.+27;1'M>BY\"S8[H\%DU]5T_$3ZVZ1$G*519(:]O$(0TID
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M&=?>=O7JIIBLCW%[TQ_WYJI9-^[G'U!+ P04    " !]29Y9H[XU*EX&  #
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M2WMO)"\$:27(2A'=&FG1AN7>2%TOQ1U7>LO\WHEL%T]_^X+>\Q]02P,$%
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M.//=A2,AJHON1=L.Y/^P.'(=':2FAP7VG<G-'OMEWP#$DK\ 4$L! A0#%
M  @ ?4F>60RAVF"T$P  LGL   X              ( !     &0Y,C0W-3AD
M.&LN:'1M4$L! A0#%     @ ?4F>65/L2RU*0   OCH! !
M ( !X!,  &0Y,C0W-3AD97@T,2YH=&U02P$"% ,4    " !]29Y90M.Z[7D+
M  !+'P  $0              @ %85   9#DR-#<U.&1E>#DY,2YH=&U02P$"
M% ,4    " !]29Y9TFID*3@#  !+"P  $0              @ $ 8   9&-T
M:"TR,#(T,3(R,RYX<V102P$"% ,4    " !]29Y9H[XU*EX&  # 0P  %0
M            @ %G8P  9&-T:"TR,#(T,3(R,U]L86(N>&UL4$L! A0#%
M  @ ?4F>65V25[BW!   ?"H  !4              ( !^&D  &1C=&@M,C R
C-#$R,C-?<')E+GAM;%!+!08     !@ & 'X!  #B;@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d924758d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dcth-20241223.xsd" xlink:type="simple"/>
    <context id="duration_2024-12-23_to_2024-12-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2024-12-23</startDate>
            <endDate>2024-12-23</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2024-12-23_to_2024-12-23"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-304">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-12-23_to_2024-12-23"
      id="Hidden_dei_EntityCentralIndexKey">0000872912</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-315">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-316">2024-12-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-317">Delcath Systems, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-318">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-319">001-16133</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-320">06-1245881</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-321">566 Queensbury Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-322">Queensbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-323">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-324">12804</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-325">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-326">489-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-327">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-328">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-329">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-330">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-331">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-332">DCTH</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-12-23_to_2024-12-23" id="ixv-333">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
